LEBER HEREDITARY OPTIC NEUROPATHY
Clinical trials for LEBER HEREDITARY OPTIC NEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new LEBER HEREDITARY OPTIC NEUROPATHY trials appear
Sign up with your email to follow new studies for LEBER HEREDITARY OPTIC NEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy for rare eye disease shows Long-Term safety in 5-Year study
Disease control CompletedThis study followed 62 people with Leber Hereditary Optic Neuropathy (LHON) who received GS010 gene therapy in earlier trials. Researchers tracked eye safety and vision changes for up to 5 years after treatment. The goal was to see if the therapy remains safe and helps maintain v…
Matched conditions: LEBER HEREDITARY OPTIC NEUROPATHY
Phase: PHASE3 • Sponsor: GenSight Biologics • Aim: Disease control
Last updated May 26, 2026 09:21 UTC
-
Gene therapy shows promise for rare eye disease
Disease control CompletedThis study tested the safety of a new gene therapy called GS010 for people with Leber Hereditary Optic Neuropathy (LHON), a genetic condition that causes sudden vision loss. Nineteen adults with a specific gene mutation received the treatment through an injection into the eye. Th…
Matched conditions: LEBER HEREDITARY OPTIC NEUROPATHY
Phase: PHASE1, PHASE2 • Sponsor: GenSight Biologics • Aim: Disease control
Last updated May 26, 2026 08:58 UTC
-
Gene therapy aims to halt blindness from rare eye disease
Disease control CompletedThis study tested a gene therapy called GS010 in 98 people with Leber hereditary optic neuropathy (LHON), a genetic condition that causes sudden vision loss. Participants received injections into both eyes and were followed for up to 5 years. The goal was to see if the treatment …
Matched conditions: LEBER HEREDITARY OPTIC NEUROPATHY
Phase: PHASE3 • Sponsor: GenSight Biologics • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
Researchers track vision loss in rare eye disease to better understand its impact
Knowledge-focused CompletedThis study looked at 44 people with Leber Hereditary Optic Neuropathy (LHON), a rare inherited eye disease that causes vision loss. Researchers reviewed medical records and asked participants about their vision and quality of life. The goal was to gather information on how the di…
Matched conditions: LEBER HEREDITARY OPTIC NEUROPATHY
Sponsor: GenSight Biologics • Aim: Knowledge-focused
Last updated May 26, 2026 09:00 UTC